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Smad2 and Smad3 (Smad2/3) are key intracellular
signal transducers for TGF-b signaling, and their tran-
scriptional activities are controlled through reversible
phosphorylation and nucleocytoplasmic shuttling.
However, the precise mechanism underlying nuclear
export of Smad2/3 remains elusive. Here we report
the essential function of RanBP3 in selective nuclear
export of Smad2/3 in the TGF-b pathway. RanBP3
directly recognizes dephosphorylated Smad2/3,
which results from the activity of nuclear Smad phos-
phatases, andmediates nuclear export of Smad2/3 in
a Ran-dependent manner. As a result, increased
expression of RanBP3 inhibits TGF-b signaling in
mammalian cells and Xenopus embryos. Conversely,
depletion of RanBP3 expression or dominant-nega-
tive inhibition of RanBP3 enhances TGFb-induced
antiproliferative and transcriptional responses. In
conclusion, our study supports a definitive role for
RanBP3 in mediating Smad2/3 nuclear export and
terminating TGF-b signaling.
INTRODUCTION
Transforming growth factor-beta (TGF-b) superfamily signaling
controls a wide variety of biological processes from develop-
ment to pathogenesis, primarily through intracellular Smad
proteins (Derynck and Miyazono, 2007). Smads are structurally
and functionally grouped into three subfamilies: five receptor-
activated Smads (R-Smads), one common Smad, and two inhib-
itory Smads. Of R-Smads, Smad2 and Smad3 (Smad2/3 there-
after for simplicity) transduce activin and TGF-b signals, whereas
Smad1, Smad5, and Smad8 transduce signals from the BMP/
GDF (bone morphogenetic proteins/growth differentiation
factor) family. Upon binding to their receptor complex at the
cell surface, TGF-b and related growth factors activate Smad
proteins and promote accumulation of Smads in the nucleus,
where they mediate transcriptional responses (ten Dijke and
Hill, 2004; Massague et al., 2005; Feng and Derynck, 2005).
Smads possess intrinsic nucleocytoplasmic shuttling
capacity, and their subcellular distribution is determined throughDeveloassociation with nuclear transport factors and retention proteins
(Watanabe et al., 2000; Pierreux et al., 2000; Inman et al., 2002b;
Nicolas et al., 2004; Schmierer and Hill, 2005). Although it has
been reported that TGF-b-induced phosphorylation favors
nuclear import of phosphorylated R-Smads (P-Smads) by
enhancing their association with importin-b (Xiao et al., 2000;
Kurisaki et al., 2001) and/or disassociation with cytoplasmic
retention factors such as SARA (Xu et al., 2000), live cell micros-
copy analysis suggest a pivotal role of nuclear export in regu-
lating TGF-b signaling. TGF-b appears not to affect the nuclear
import rate of Smad2 (Schmierer and Hill, 2005). Instead, it
decreases Smad2 nuclear export, thereby retaining more phos-
phorylated Smad2 in the nucleus (Xu et al., 2002; Schmierer and
Hill, 2005). Conversely, dephosphorylation of P-Smad2/3 by
phosphatase PPM1A promotes nuclear export of Smad2/3
(Lin et al., 2006). Therefore, the phosphorylation status of
R-Smads is coupled with their nuclear accumulation (Xu et al.,
2002; Inman et al., 2002b; Lin et al., 2006). It is generally thought
that the level of nuclear R-Smads determines the duration and
strength of signaling.
Unlike common Smad4 and BMP-specific Smad1, whose
nuclear export dependson the function ofCRM1, aLeptomycinB
(LMB)-sensitive export receptor (Watanabe et al., 2000; Pierreux
et al., 2000; Xiao et al., 2001, 2003), TGF-b-specific Smad2/3
undergo nuclear export in a LMB-insensitive manner and appear
to be independent of CRM1 function or Smad4 export (Pierreux
et al., 2000; Inman et al., 2002b; Nicolas et al., 2004; Schmierer
and Hill, 2005). It has been reported that Smad3 nuclear export
involves TGF-b-dependent interaction with Exportin 4 (Kurisaki
et al., 2006) and TGF-b-independent interaction with nucleopor-
ins (Xu et al., 2002). Given highly conserved putative NESs and
Exportin-4-binding motifs between BMP- and TGF-b-specific
R-Smads (Xiao et al., 2001; Kurisaki et al., 2006), it remains
unresolved how export mediators discriminate between these
R-Smads.
In this study,weprovide compelling evidence that Ran-binding
protein 3 (RanBP3) serves as a direct mediator for nuclear export
of Smad2/3. Originally identified as an interaction partner with
guanine nucleotide exchange factor (RCC1) (Mueller et al.,
1998), RanBP3 has been implicated in the process of nucle-
ocytoplasmic trafficking by its ability to bind to a few proteins
including Ran, nuclear pore components, and CRM1 (Mueller
et al., 1998; Englmeier et al., 2001; Lindsay et al., 2001). We
found RanBP3 directly interacts with Smad2/3 in theirpmental Cell 16, 345–357, March 17, 2009 ª2009 Elsevier Inc. 345
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RanBP3 Terminates Smad2/3 Signalingdephosphorylated form, but not with Smad1. Consistent with
its role in exporting Smad2/3, RanBP3 negatively regulates
TGF-b signaling. Knockdown of RanBP3 or blockade of the
RanBP3-Smad2/3 interaction inhibits Smad2 nuclear export
and enhances TGF-b-induced responses. In accordance,
RanBP3 represses activin/Smad2, but not BMP/Smad1,
signaling in Xenopus embryos. These findings support the notion
that nuclear export of R-Smads is selectively controlled by
specific export mediators in the process of TGF-b signal
termination.
RESULTS
RanBP3 Inhibits Smad2/3-Mediated Transcriptional
Responses in Mammalian Cells
In an attempt to identify novel intracellular factors controlling
TGF-b signaling, we discovered that RanBP3 was a strong
candidate for mediating nuclear export of Smad2/3. As a first
step in evaluating a possible role of RanBP3 in TGF-b signaling,
we examined the effects of RanBP3 on Smad2/3-mediated tran-
scriptional activation using various Smad-dependent gene
reporters. Increased expression of human or mouse RanBP3
caused a decrease in TGF-b-dependent transcription from the
Smad-binding element (SBE)-Luc reporter (Figure 1A; data not
shown). RanBP3 also inhibited TGF-b-induced activation of the
natural p21 promoter in HaCaT cells (Figure 1B), as well as the
p15 promoter and the plasminogen activator inhibitor type 1
(PAI-1) promoter in HepG2 cells (data not shown). However,
RanBP3-wv, a mutant that loses its Ran-binding activity (Eng-
lmeier et al., 2001), failed to block TGF-b-induced promoter
activation, although the mutant was expressed at a similar level
to that of RanBP3 (Figure 1C). In sharp contrast to its ability
to regulate TGF-b signaling, RanBP3 did not interfere with
BMP-induced activation of the Id1 promoter in C2C12 cells
(Figure 1D) or HepG2 cells (see Figure S3 available online), sug-
gesting that RanBP3 specifically acts on TGF-b, but not BMP,
signaling.
Consistent with the ability of RanBP3 to inhibit activation of
TGF-b-responsive promoters, HaCaT cells stably expressing
RanBP3 (Figure 1H, blot a) diminishedTGF-b-mediated induction
of endogenous p15, p21, and PAI-1 mRNAs (Figures 1E–1G). In
addition, the protein level of p21 was also reduced (Figure 1H,
blot b). Overexpression of RanBP3, however, did not disrupt
the TGF-b-induced C-terminal phosphorylation of Smad2/3
(Figure 1H, blots c and d), nor did it affect the total level of
Smad2/3 in the same stable cells (Figure 1H, blot e). These data
suggest that RanBP3 acts downstream of Smad2/3 activation.
RanBP3 Suppresses Activin, but Not BMP,
Signaling in Xenopus Embryos
During early vertebrate development, activin/nodal and BMP
signals are known to control embryonic patterning and cell fate
determination (Chang et al., 2002). Activation of TGF-b signaling
induces mesoderm- and endoderm-specific gene expression in
a dose-dependent fashion in early Xenopus embryos. To
examine whether RanBP3 can regulate TGF-b signaling during
Xenopus embryogenesis, we examined the effects of RanBP3
on activin- or BMP-induced endogenous gene expression in
Xenopus ectodermal explants (animal caps). As shown in346 Developmental Cell 16, 345–357, March 17, 2009 ª2009 ElsevieFigure 1I, activin induced a whole range of mesendodermal
markers, including the endodermal marker Sox17a, the dorsal
mesodermal marker chordin, the ventrolateral mesodermal
marker XWnt8, and the pan-mesodermal marker XBra at
gastrula stages (lane 2), whereas BMP4 induced the expression
of Sox17a, XWnt8, and Xbra (lane 5). Coexpression of wild-type
RanBP3, but not RanBP3-wv, completely suppressed activin-
induced expression of Sox17a and chordin, and moderately
reduced the expression of Xbra and XWnt8 (lanes 3 and 4). In
contrast, RanBP3 or RanBP3-wv failed to block the expression
of the genes activated by BMP4, including Sox17a, Xwnt8, and
XBra (lane 6). These results further support the notion that
RanBP3 preferentially blocks activin, but not BMP, signaling in
a Ran-binding-dependent manner.
Knockdown of RanBP3 Enhances TGF-b Growth
Inhibitory and Transcriptional Responses
We next investigated whether RanBP3 depletion enhances
TGF-b responses. We first established HaCaT cell lines that
stably express distinct shRNAs against separate target
sequences of RanBP3, i.e., shRNA494 (designated RanBP3-
KD1) or shRNA-676 (designated RanBP3-KD2 and KD3) (Figures
2A and 2E). It is clear that depletion of RanBP3 enhanced TGF-b-
induced expression of both the SBE-Luc reporter (Figure 2B) and
the natural genes, including those encoding PAI-1, and CDK
inhibitors p15 and p21 (Figure 2C). Consistent with the increased
mRNA levels of p15 and p21, depletion of RanBP3 rendered cells
more sensitive to TGF-b-induced growth inhibition (Figures 2D
and 2E). Collectively, these data established a previously unde-
fined role of RanBP3 as negative modulator in TGF-b-mediated
transcriptional responses.
RanBP3 Enhances Nuclear Export of Smad2/3
Because RanBP3 has been implicated in nuclear export by its
ability to bind Ran, nuclear pore components, and CRM1 (Muel-
ler et al., 1998; Englmeier et al., 2001; Lindsay et al., 2001), we
sought to evaluate whether RanBP3 has a direct role in regu-
lating Smad2/3 nuclear export. The ability of RanBP3 to affect
TGF-b-induced nuclear accumulation of endogenous Smad3
was examined in HaCaT cells. As seen in Figure 3A, indirect
immunostaining of Smad3 revealed that overexpression of
RanBP3 decreased the intensity of nuclear Smad3 by 55.3%
(±4.2%). Similar results were observed with mouse RanBP3
(data not shown). To further confirm this observation, TGF-b-
induced nuclear accumulation of endogenous Smad2 was
examined in parental HaCaT cells, RanBP3-expressing stable
cells (RanBP3-OE), and RanBP3 knockdown cells (RanBP3-
KD1). The results demonstrate that the level of nuclear Smad2/3
is inversely proportional to that of RanBP3 in the nucleus. As
shown in Figure 3B, TGF-b stimulation rapidly induced Smad2
accumulation in the nucleus in parent HaCaT cells. Increased
expression of RanBP3 reduced the level of nuclear Smad2 in
RanBP3-OE cells, while knockdown of endogenous RanBP3
expression rendered more endogenous Smad2 accumulated in
the nucleus of RanBP3-KD1 cells.
To specifically evaluate Smad2/3 export without interference
of continuous import, we next examined the TGF-b-induced
nuclear accumulation of Smad2/3 in the presence of TbRI inhib-
itor SB431542, which blocks Smad2/3 phosphorylation in ther Inc.
Developmental Cell
RanBP3 Terminates Smad2/3 SignalingFigure 1. RanBP3 Inhibits TGF-b-Induced Transcriptional Responses in Mammalian Cells
(A) The SBE-luc reporter activity was measured in HaCaT cells that were cotransfected with Myc-RanBP3 and treated with 2 ng/ml of TGF-b (20 hr). Values and
error bars represent mean and standard deviation of three experiments.
(B) Effect of RanBP3 on the natural p21 promoter in HaCaT cells.
(C) RanBP3-wv, defective in Ran binding, fails to affect SBE-luc response. SBE-Luc reporter was cotransfected into HaCaT cells with Myc-RanBP3 (WT) or Myc-
RanBP3-wv (wv), and treated with SB431542 (SB) or TGF-b. The expression level of RanBP3 (TGF-b-treated) was examined by using western blotting (bottom).
(D) Effect of RanBP3 on BMP responses. C2C12 cells were transfected with Myc-RanBP3 and Id1-Luc reporter. Luciferase activity was measured 20 hr after
treatment with 25 ng/ml of BMP2.
(E) Quantitative real-time RT-PCR (qRT-PCR) analysis of p15 mRNA. RanBP3-OE (stably expressing Flag-RanBP3) cells and parental HaCaT cells were stimu-
lated with TGF-b up to 8 hr before total RNAswere harvested. The data weremeasured in triplicate. Values and error bars represent mean and standard deviation.
(F) qRT-PCR analysis of p21 mRNA.
(G) qRT-PCR analysis of PAI-1 mRNA.
(H) Western analysis of p21 protein. RanBP3-OE or parental HaCaT cells were treated with TGF-b for 4 hr and harvested at indicated times. The expression levels
of RanBP3, p21, Smad2/3, and Smad2/3 phosphorylation were examined by western blotting with appropriate antibodies as indicated. b-actin blot serves as
a loading control.
(I) Mesodermal and endodermal marker induction in Xenopus ectodermal explants. The gene expression in uninjected control animal caps (lane 1) and in whole
embryos processed in the absence or presence of reverse transcriptase in RT-PCRs (lanes 8 and 9) are shown. The expression level of EF-1a was used as the
loading control.cytoplasm and nuclear accumulation thereafter (Laping et al.,
2002; Inman et al., 2002a). In parental HaCaT cells, Smad2 and
Smad4were accumulated in the nucleus after 2 hr of TGF-b stim-Develoulation, but redistributed throughout thewhole cells after removal
of TGF-b and simultaneous addition of SB431542 for 2 hr. Treat-
ment with CRM1 inhibitor LMB blocked Smad4, but not Smad2,pmental Cell 16, 345–357, March 17, 2009 ª2009 Elsevier Inc. 347
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RanBP3 Terminates Smad2/3 Signalingredistribution (Figure 3C, top panels). In RanBP3-KD1 cells, sus-
tained Smad2 nuclear localization was observed in the absence
or presence of LMB (Figure 3C, second row from the bottom). On
the contrary, knockdown of RanBP3 did not affect Smad4
cellular redistribution (Figure 3C, bottommost panels).
We next sought to specifically examine how much Smad2/3
are exported into the cytoplasm. To this end, cells were similarly
treated as in Figure 3C and harvested at different time points
during the 4 hr export process. Smad2/3 levels in the cyto-
plasmic versus nuclear fractions at each time point were
analyzed by western blotting. The quality of cytoplasmic/nuclear
fractionation was determined by the presence of cytoplasmic
GADPH and nuclear Lamin A/C in the fractions. At time point 0
(immediately after 60 min TGF-b treatment), a very low level of
Smad2/3 in the cytoplasmic fractions of both wild-type and
knockdown cell lines was detected, indicating most of the
Smad2/3 resided in the nucleus. SB431542 treatment promoted
the cycling back of Smad2/3 in the cytoplasm in parental HaCaT
cells, as indicated by the gradual increase in the level of cyto-
plasmic Smad2/3 and the corresponding decrease in the nuclear
Smad2/3 (Figure 3D). In contrast, knockdown of RanBP3 slowed
down the nuclear-to-cytoplasmic shift of Smad2/3 in RanBP3-
KD1 cells (Figure 3D). Taken together, the data in Figure 3
support the notion that RanBP3 positively regulates the nuclear
export of Smad2/3.
RanBP3 Enhances Smad2 Nuclear Export
in a Ran-Binding-Dependent Manner
Since RanBP3 is a Ran-binding protein, we sought to examine
whether RanBP3 requires Ran to export Smad2/3 by using an
in vitro export assay. In these assays, HaCaT cells stably ex-
pressing GFP-Smad2 were first treated with TGF-b for 2 hr to
induce Smad2 nuclear accumulation, and then pulsed with digi-
tonin for 5min to permeabilize cell membrane. After washing, the
remaining level of GFP-Smad2, which represented nuclear
Smad2 that was not exported, was determined by western blot-
ting analysis. Several dosages of digitonin were tested to
produce substantial loss of cytoplasmic proteins yet retain the
intact nuclear envelope (Figure S1). To avoid overpermeabiliza-
tion, we chose 30 ng/ml of digitonin in the subsequent assays.
Proper cell membrane permeabilization was confirmed by lack
of GAPDH in the total lysates of permeabilized cells (Figure 4A).
In addition, functional integrity of the nuclear envelope was as-
sessed by similar levels of GFP-Smad2 in digitonin-permeabi-
lized and nonpermeabilized cells at time point 0 (normalized
against that of Lamin A/C) as well as by the disappearance of
cytoplasmic GADPH after 5 min of digitonin treatment
(Figure 4A, lane 4). In vitro export of GFP-Smad2 was progres-
sive over time, as indicated by a reduced level of GFP-Smad2
protein (Figure 4A, lanes 4–6) or diminished GFP fluorescence
(data not shown) in the permeabilized cells. Retention of GFP-
Smad2 in the nucleus appeared to partially, if not completely,
depend on Ran activity and energy because it decreased after
addition of recombinant Ran proteins to the cells (lanes 9 and
10) and increased when incubated on ice (lanes 7 and 8).
We then analyzed the effect of the Ran-binding deficiency of
RanBP3-wv on Smad2 export. Albeit at low efficiency, recombi-
nant RanBP3 and RanBP3-wv proteins could similarly enter the
nucleus of permeabilized cells (Figure S2). It is apparent that
RanBP3 was capable of exporting Smad2 (Figure 4B, lanes 4
and 5). In sharp contrast, RanBP3-wv had no effect on Smad2
export in vitro (lanes 6 and 7). To further compare the effect of
RanBP3 or RanBP3-wv mutant, we also used a highly sensitive
quantitative export assay (Cullen, 2004), which has been previ-
ously used to analyze Smad2 nuclear export (Xu et al., 2002;
Lin et al., 2006). Consistent with our data in vitro, we found
that RanBP3 increased Smad2 export by 5.2-fold, whereas
RanBP3-wv failed to produce any effects (Figure 4C). These
results strongly suggest that RanBP3 promotes Smad2 nuclear
export in a Ran-dependent manner.
Figure 2. Knockdown of RanBP3 Enhances
TGF-b Growth Inhibitory and Transcrip-
tional Responses
(A) RanBP3 expression in HaCaT cell lines stably
expressing RanBP3 shRNAs was examined by
anti-RanBP3 western blotting. Whole-cell lysates
were prepared from HaCaT cell lines stably ex-
pressing shRNA-494 (designated RanBP3-KD1),
shRNA-676 (RanBP3-KD2), or empty pSRG
vector (CTRL). b-actin served as a loading control.
(B) Luciferase activity of SBE-Lucwas examined in
RanBP3 knockdown stable cells and control
HaCaT cells.
(C) Western blotting analysis of PAI-1, p15, and
p21. Whole-cell lysates from RanBP3-KD1 and
control HaCaT cells were immunoblotted with
antibodies shown on the right. An anti-b-actin
immunoblot serves as a loading control.
(D) Proliferation of HaCaT stable clone RanBP3-
KD1 and control cells was examined using MTT
assays (Promega) according to manufacture’s
instructions. The data weremeasured in duplicate.
Values and error bars represent mean and stan-
dard deviation.
(E) Proliferation of HaCaT stable clone RanBP3-
KD3 and control cells. RanBP3 expression was
examined by anti-RanBP3 western blotting (left).348 Developmental Cell 16, 345–357, March 17, 2009 ª2009 Elsevier Inc.
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Having established the role of RanBP3 in mediating nuclear
export of Smad2/3, we investigated whether RanBP3 could
physically associate with Smads. A coimmunoprecipitation
(co-IP) assay was used to examine the ability of RanBP3 to
interact with Smads in transfected HEK293 cells. We detected
the presence of RanBP3 in the immuno-complex of Smad2
(Figure 5A, lanes 2 and 3), but not in that of Smad1 (Figure 5A,
lanes 4 and 5). RanBP3 could also bind to Smad3 (Figure 5B,
lanes 1 and 2), which is the closest homolog of Smad2 and
also functions as TGF-b signal transducer. The interaction of
RanBP3 with Smad4, a common Smad for both TGF-b and
BMP signaling, was comparatively weaker (Figure 5B, lanes 3
and 4). Furthermore, immunoprecipitation of endogenous
RanBP3 retrieved endogenous Smad2 and Smad3 proteins in
HaCaT cells (Figure 5C, lane 4). Taken together, these data
reveal an interaction between RanBP3 and TGF-b-specific
Smad2/3 under physiological conditions. Notably, activation of
the TGF-b receptor appeared to decrease the Smad2/3-RanBP3
interaction (Figure 5C, lane 5; see below).
We further examined the RanBP3-Smad3 interaction by
mapping their respective interacting domains. As shown in
Figure 5D, both the N-terminal MH1 domain and C-terminal
MH2 domain could bind to RanBP3 in vitro. The domains in
Figure 3. RanBP3 Enhances Nuclear Export
of Smad2/3
(A) Smad3 nuclear accumulation. HaCaT cells
were transfected with Myc-RanBP3, and 24 hr
after transfection, treated with TGF-b for 2 hr and
fixed. The localization of endogenous Smad3
was examined by indirect immunostaining with
anti-Smad3 antibody. Cells that received Myc-
RanBP3 were demonstrated by anti-Myc immu-
nostaining, indicated by white arrows. Quantifica-
tion of nuclear Smad3 (immunostaining intensity)
in RanBP3-transfected cells (RanBP3+, n = 15)
and RanBP3 nontransfected cells (RanBP3,
n = 45) from multiple experiments is shown on
the right. Error bars represent standard deviation.
(B) Distribution of Smad2. HaCaT stable cells ex-
pressing Flag-RanBP3 (RanBP3-OE) or
shRanBP3-433 (RanBP3-KD1) as well as parental
cells were treated with TGF-b for 2 hr and fixed.
RanBP3 and Smad2 were visualized by indirect
immunostaining with anti-RanBP3 and anti-
Smad2 antibodies, respectively.
(C) Effect of RanBP3 depletion on the level of
nuclear Smad2. RanBP3-KD1 and parental Ha-
CaT cells were treated with TGF-b for 2 hr to
induce nuclear accumulation of Smad2. Cells
were washed three times to remove TGF-b and
then treated with SB431542 (5 nM) and/or LMB
(20 ng/ml) for another 2 hr before fixation. Endog-
enous Smad2 and Smad4 were visualized by indi-
rect immunostaining with anti-Smad2 and anti-
Smad4 antibodies, respectively. Fluorescence
images were acquired with the same exposure
parameters for intensity comparison.
(D) Cytoplasmic and nuclear fractionation.
RanBP3-KD1 and parental HaCaT cells were
treated with TGF-b for 1 hr, and cells were washed
three times to remove TGF-b and treated with
SB431542 up to 4 hr. Cells were then harvested
at indicated times, and both the nuclear and cyto-
plasmic fractions were collected. The total
Smad2/3 levels as well as the P-Smad2 level
were examined. The nuclear-localized protein
Lamin A/C and cytoplasmic-localized protein
GADPH demonstrate separation of the fractions
and proper sample loading. The relative level of
cytoplasmic Smad3 (Smad3/GAPDH) was quanti-
fied using NIH Image. The arbitrary unit for cyto-
plasmic Smad3 in control cells at 4 hr of
SB431542 treatment was set to 1. Values and error
bars represent means and standard deviations of
three experiments.Developmental Cell 16, 345–357, March 17, 2009 ª2009 Elsevier Inc. 349
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RanBP3 Terminates Smad2/3 SignalingFigure 4. RanBP3 Mediates Smad2 Export
Dependent on Its Ran-Binding Ability
(A) In vitro export of Smad2. Stable HaCaT cells
expressing GFP-Smad2 were permeabilized with
digitonin (30 ng/ml) for 5 min and then incubated
in a reaction buffer containing either BSA or Ran
at 30C or on ice. GFP-Smad2 was examined by
anti-Smad2 antibody western blotting (80 kDa).
Lamin A/C and GADPH indicate levels of nuclear
and cytoplasmic proteins. The relative level of
nuclear GFP-Smad2 (Smad2:Lamin A) was quan-
tified from multiple experiments. The arbitrary
unit for nuclear GFP-Smad2 in lane 4 was set to
1. Values and error bars represent means and
standard deviations of three experiments.
(B) The effect of RanBP3 or RanBP3-wv protein on
Smad2 export.
(C) A quantitative Smad2 export assay (see Exper-
imental Procedures) was used to examine the
effect of RanBP3 or the RanBP3-wv mutant on
Smad2 export. Values and error bars represent
means and standard deviations of three experi-
ments.RanBP3, namely the N-terminal domain (N), intermediate
domain (F), and C-terminal Ran:GTP-binding domain (R) (Mueller
et al., 1998; Lindsay et al., 2001), all associated with Smad3, yet
more weakly than the full-length RanBP3 (Figure 5E). Among all
the domains, R apparently exhibited stronger affinity to Smad3
than N or F (Figure 5E, lane 4) and directly interacted with
Smad3 in vitro (Figure 5F, lane 3).
To further identify the structural determinants that define the
RanBP3-interacting specificity of Smad3, we generated a series
of chimeras between Smad1 (unable to bind to RanBP3) and
Smad3 (able to bind to RanBP3). In these chimeras, one or two
domains of Smad3 were replaced with counterpart(s) of Smad1
(Figure 5G, right panel). The ability of these chimeras to bind to
RanBP3 was assessed and compared with wild-type Smad3 in
co-IP experiments. As observed earlier, RanBP3 interacted
with wild-type Smad3, but not Smad1 (Figure 5G, lanes 2 and
3). RanBP3 also interacted with Smad1-Smad3 chimeras con-
taining theMH1 and/orMH2domains of Smad3 (Figure 5G, lanes
4, 5, and 7–9). However, RanBP3 did not interact with Smad131
with the linker region only of Smad3 (Figure 5G, lane 6), suggest-
ing that theMH1 andMH2 domainsmediate the RanBP3-Smad3
interaction. Interestingly, among all the chimeras, Smad313,
which contains both the MH1 and MH2 domains of Smad3, ex-
hibited the strongest interaction with RanBP3, comparable to
that of wild-type Smad3 (Figure 5G, lanes 3 and 8). Taken
together, data in Figure 5 suggest that at least two different
epitopes in Smad3 are recognized by RanBP3 and cooperatively
mediate the Smad3-RanBP3 interaction.
RanBP3 Binds to Smad2/3 in Their Unphosphorylated
Forms
As shown in Figure 5, the interaction between RanBP3 and
Smad2/3 was apparently weaker in the presence of active
TGF-b signaling, either by expression of a constitutively active
mutant form of TbRI, i.e., ALK5(T202D) (Figure 5A, lane 3) or
TGF-b ligand stimulation (Figure 5C, lane 5). Since RanBP3
resides in the nucleus (Mueller et al., 1998) (Figures 3A and350 Developmental Cell 16, 345–357, March 17, 2009 ª2009 Elsevie3B), where Smad2/3 dephosphorylation by nuclear phosphatase
PPM1A also occurs (Lin et al., 2006), we examined the effect of
PPM1A on the RanBP3-Smad3 interaction. The level of TGF-b-
induced Smad3 phosphorylation was reduced by PPM1A, but
was not affected by overexpressed RanBP3 (Figure S4).
Notably, increased expression of PPM1A clearly enhanced the
association between RanBP3 and Smad3 (Figure 6A, lanes 3
and 4). These data support the notion that RanBP3 preferentially
binds to dephosphorylated Smad2/3.
We then carried out co-IP experiments to examine the Smad2
SXS motif mutant that either lacks the C-terminal serine phos-
phorylation (inactive, 2SA) or harbors phosphorylation-mimetic
residues (active, 2SD). Analysis of the results revealed different
binding affinities of these mutants toward RanBP3. As shown
in Figure 6B, RanBP3 pulled down more Smad2(2SA) than
Smad2(2SD) mutant (lanes 3 and 4). Since the SXS motif phos-
phorylation induces Smad2/3-Smad4 interaction, we sought to
determine whether TGF-b-induced Smad2-Smad4 interaction
contributed to the decreased association between Smad2 and
RanBP3. As shown in Figure 6C, overexpression of Smad4 did
not affect the interaction between RanBP3 and the Smad2(2SD)
mutant (lanes 2 and 3), which readily interact with Smad4 in the
absence of TGF-b stimulation (data not shown). Overexpression
of RanBP3 also had no affect on the interaction between the
Smad2(2SD)mutant and Smad4 (Figure 6D). These data suggest
that Smad4 and RanBP3 do not interfere with each other for
binding to Smad2/3.
To further explore how the phosphorylation affects the
RanBP3-Smad2/3 interaction, we carried out in vitro binding
assays to examine the RanBP3 interaction with the recombinant
Smad2 MH2 (aa 241–467) protein either in its phosphorylated or
unphosphorylated form. The results revealed that GST-RanBP3
could bind to unphosphorylated Smad2MH2 domain (Figure 6E,
lane 1), but had no binding affinity to the phosphorylated Smad2
MH2 domain (Figure 6E, lane 2). Collectively, these data estab-
lish that RanBP3 preferentially binds to unphosphorylated and
recently dephosphorylated Smad2/3.r Inc.
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To identify the subcellular compartment where RanBP3 interacts
with Smad2/3, we used a YFP-based fluorescence complemen-
tation system that allows easy visualization of protein interac-
tions with microscopy (Hu et al., 2002). In this system, YFP frag-
ment YN (aa 1–154) and YC (aa 155–238) were separately fused
Figure 5. RanBP3 Interacts with TGF-b-Specific Smad2 and Smad3
(A) Coimmunoprecipitation (Co-IP) of Smads and RanBP3. HEK293T cells were transfected with indicated expression plasmids for RanBP3, Smad1 or Smad2,
and a constitutively active receptor ALK5(T202D) (lane 3) or ALK3(Q233D) (lane 5). Levels of Smads and RanBP3 in the IP products and whole-cell lysates (WCL)
were analyzed by western blotting.
(B) Co-IP of RanBP3 and Smad3.
(C) Endogenous RanBP3-Smad2/3 interaction. HaCaT cells at 90% confluency were treated with or without TGF-b for 2 hr before harvest. RanBP3-bound
Smad2/3 were immunoprecipitated with an anti-RanBP3 antibody and detected by anti-Smad2/3 western blotting. The anti-mouse IgG immunoprecipitates
in lane 3 serve as negative control.
(D) Mapping of RanBP3-binding domains of Smad3. 35S-labeled Smad3MH1 domain, MH2 domain, as well as the linker region plusMH2 domain were incubated
with GST-RanBP3 protein on glutathione beads. Retrieved proteins were separated by SDS-PAGE and visualized by autoradiography. GFP serves as a negative
control.
(E) Mapping of Smad-binding domains of RanBP3.
(F) The Ran-binding domain of RanBP3 (RanBP3-R) interacts with Smad3 in GST pull-down assay.
(G) The MH1 andMH2 domains confer the maximum binding of Smad3 to RanBP3. HEK293T cells were transfected with Myc-RanBP3, HA-Smad1, HA-Smad3,
as well as HA-Smad1/3 domain chimera as indicated. Co-IP experiments were conducted similarly as in (A).Developmental Cell 16, 345–357, March 17, 2009 ª2009 Elsevier Inc. 351
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Unphosphorylated Form in the Nucleus
(A) Effect of increasing dosages of PPM1A on the
Smad3-RanBP3 interaction. HEK293T cells were
transfectedwith expressionplasmids as indicated.
(B) Binding of RanBP3 to Smad3 mutants in co-IP
experiments. Myc-RanBP3 was cotransfected
into HEK293T cells with Smad2 wild-type (WT),
Smad2mutant lacking the C-terminal serine phos-
phorylation (2SA), or active Smad2 mutant
harboring C-terminal serine phosphorylation-
mimetic residues (2SD).
(C) The interaction between Myc-RanBP3 and
Flag-Smad2(2SD) in the presence of HA-Smad4.
(D) Effect of RanBP3 on the interaction between
HA-Smad4 and Flag-Smad2(2SD).
(E) Binding of RanBP3 to the unphosphorylated
MH2 domain of Smad2 (S2MH2). Recombinant
S2MH2 or phosphorylated S2MH2 (P-S2MH2)
was incubated with GST-RanBP3 proteins (or
GST only as a negative control) on glutathione
beads. S2MH2 or GST proteins were demon-
strated by western blots with anti-Smad2 or anti-
GST antibody, respectively.
(F) Visualization of the RanBP3-Smad2/3 interac-
tions in BiFC assays. HaCaT cells were cotrans-
fected with expression plasmids as indicated.
Images of reconstituted YFP fluorescence (cells
in cyan boxes) were acquired 24 hr after transfec-
tion. Cells that received the YC-RanBP3/YN pair
or the YN-Smad2/YC pair were also immuno-
stained with anti-RanBP3 (image c) or anti-
Smad2 antibody (image d), respectively. DAPI
staining indicates the nucleus.
(G) Effect of TGF-b on the RanBP3-Smad3 interac-
tion in BiFC assays. YC-RanBP3/YN-Smad3 co-
transfected HaCaT cells were treated for 2 hr with
TGF-b (a), overnight with SB431542 (b), or 0.02%
FBS (c).
(H) DNA-binding assay of Smad3. The DNA-Smad
complex was affinity-purified using biotinylated
SBE from RanBP3-KD1 cells and parent HaCaT
cells, and then examined by using western blotting
with the indicated antibodies.with each of the interacting protein partners. Protein interaction
brings together the two YFP halves to reconstitute a functional
YFP that produces a fluorescent signal. In HaCaT cells coex-
pressing YC-RanBP3 and YN-Smad3, YFP fluorescence was
detected in the nucleus in the absence of TGF-b (Figure 6F, set
a); similar results were observed when the reverse pair, i.e.,
YN-RanBP3 and YC-Smad2, were used (Figure 6F, set b). As
negative controls, the YC-RanBP3/YN-vector pair and YN-
Smad2/YC-vector pair did not yield fluorescence (Figure 6F,
sets c and d).
We next examined how the RanBP3-Smad2 interaction
responds to TGF-b. As shown in Figure 6G, endogenous
Smad2 resided in both the cytoplasm and the nucleus in HaCaT
cell at the resting state (0.02% FBS treatment overnight). While
TGF-b stimulation for 2 hr induced nuclear accumulation of
Smad2, TbRI inhibitor SB431542 rendered Smad2 mostly accu-
mulated in the cytoplasm. The distribution of transiently ex-
pressed YC-Smad2 mimics endogenous Smad2. When YC-
Smad2 and YN-RanBP3 were coexpressed, YFP fluorescence
resided exclusively in the nucleus under all the conditions exam-352 Developmental Cell 16, 345–357, March 17, 2009 ª2009 Elsevieined, strongly suggesting that RanBP3 interacts with Smad2/3 in
the nucleus regardless TGF-b signaling.
RanBP3 Does Not Affect the DNA-Binding Ability of
Smad3
As RanBP3 also associates with the MH1 domain of Smad3
(Figure 5D, lane 2), we sought to examine whether RanBP3
would affect Smad3’s DNA-binding ability by using a DNA pull-
down assay. The biotin-labeled SBE oligo comprises of four
copies of the SBEs and was used to retrieve SBE-containing
complex from the lysates of HaCaT control cells and RanBP3-
KD1 stable cells. As shown in Figure 6H, TGF-b induced binding
of Smad3 and Smad4 to biotinylated SBE (lane 3 and 5). RanBP3
was undetectable in the SBE-containing complex (lane 2 and 3),
which is consistent with its position downstream of Smad
complex dissociation and dephosphorylation of Smad3. More-
over, RanBP3 depletion did not affect the level of SBE-bound
Smad3 (lane 5), suggesting that RanBP3 would not affect
Smad3’s DNA-binding activity.r Inc.
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RanBP3 Terminates Smad2/3 SignalingFigure 7. RanBP3 Controls Smad2/3 Export
and TGF-b Signaling via Its Contact with
Smad2/3
(A) Effect of Flag-NLS-RanBP3-R (Flag-NLS-R) on
the RanBP3-Smad2 interaction. HEK293T cells
were transfected with indicated expression plas-
mids, and co-IP experiments were carried as
described in Figure 4A.
(B) Effect of Flag-NLS-R on the RanBP3-Smad3
interaction.
(C) Effect of Flag-NLS-R on RanBP3-mediated
Smad2 export was examined using a quantitative
Smad2 export assay. Values and error bars repre-
sent means and standard deviations of two exper-
iments.
(D) Effect of Flag-NLS-R on the SBE-luc reporter
activity. Flag-NLS-R was cotransfected into Ha-
CaT cells, and the SBE-Luc reporter activity was
measured 20 hr after TGF-b stimulation.
(E) A workingmodel for Smad2/3 transport. During
TGF-b signal transduction (indicated by green
arrows), receptor-phosphorylated Smad2/3 form
a complex with Smad4. The heteromeric Smad
complex is then recruited to the transcriptional
machinery via its binding to the promoter, Smad-
cooperating transcription factors (TFX), and coac-
tivators (Co-A) such as p300/CBP, TAZ, and the
Mediator complex. During signal termination (red
arrows), Smad2/3 become dissociated and de-
phosphorylated by PPM1A. Dephosphorylated
Smad2/3 is then exported out of the nucleus by
RanBP3 in a Ran-dependent manner. Signal
transduction may be reinitiated, dependent on
receptor activity. TbR, TGF-b receptor complex;
GTF, general transcription factors.RanBP3-R Dominantly Blocks Smad2 Export
and Enhances TGF-b Signaling
To evaluate how the RanBP3-Smad interaction modulates
Smad2/3 export as well as TGF-b signaling, we explored the
use of the Smad-interacting region in RanBP3 as a competitive
inhibitor for this interaction. The RanBP3-R resides in the cyto-
plasm when exogenously expressed (Welch et al., 1999). Since
RanBP3 interacts with Smad2/3 in the nucleus (Figures 6F and
6G) and partly through the R domain of RanBP3 (Figures 5E
and 5F), we introduced the nuclear localization signal (NLS) in
the N terminus of RanBP3-R (termed NLS-R) in order to force
RanBP3-R to be localized in the nucleus. When NLS-R was co-
transfected with RanBP3, the association of RanBP3 with
Smad2 (Figure 7A) and Smad3 (Figure 7B) was disrupted in
HEK293T cells, clearly demonstrating that RanBP3-R competes
with RanBP3 for Smad2/3 binding. We then examined the
effect of NLS-R in Smad2 export and TGF-b-induced transcrip-
tional responses. Quantitative Smad2 export assay revealed
that NLS-R attenuated RanBP3-mediated Smad2 export in
a dose-dependent manner (Figure 7C). Consistently, NLS-R
enhanced the TGF-b-induced SBE-luc response in HaCaT cells
(Figure 7D). Collectively, these data suggest that through itsDevelodirect interaction with Smad2/3, RanBP3 mediates the nuclear
export of Smad2/3 and hence functions as a negative modulator
in TGF-b signaling.
DISCUSSION
Stringent control of activation and termination of TGF-b
signaling is critical for normal cell physiology. Deregulation of
the TGF-b signaling pathway has been associated with the
pathogenesis of cancer and other diseases (Massague et al.,
2000; Bierie and Moses, 2006; ten Dijke and Arthur, 2007).
Though much effort during the past decade has focused on
activation of TGF-b signaling, increasing evidence suggests
that modulation of TGF-b signaling decay also plays important
roles in the maintenance of a balanced signaling level. TGF-b
signaling can be terminated in different ways, such as dephos-
phorylation of R-Smads, degradation of Smad proteins, or
nuclear exclusion of Smad signal transducers. Recent work
demonstrates that a phosphatase-dependent mechanism oper-
ates in the export of dephosphorylated Smad2 out of the
nucleus during termination of TGF-b signaling (Inman et al.,
2002b; Nicolas et al., 2004; Schmierer and Hill, 2005). Althoughpmental Cell 16, 345–357, March 17, 2009 ª2009 Elsevier Inc. 353
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promote nuclear export of Smad2 (Lin et al., 2006), the exact
export machinery that transports dephosphorylated Smad2
out of the nucleus has not been elucidated. In this study, we
identify RanBP3 as the key component that mediates Smad2/3
nuclear export.
RanBP3 is a nuclear Ran-binding protein. In addition to its
C-terminal domain that has the Ran-binding capacity, the
N-terminal sequences of RanBP3 contain several FXFG motifs
that are characteristic of a subgroup of nucleoporins (Mueller
et al., 1998). The ability of RanBP3 to mediate nuclear export
of Smad2/3 depends on its direct association with Smad2 and
Smad3, as demonstrated by a series of biochemical and immu-
nofluorescence experiments. RanBP3 interacts with Smad2/3
primarily through its C-terminal R domain, and it shows strong
preference for unphosphorylated Smad2/3 (Figures 5 and 6).
The binding occurs in the nucleus (Figures 6F and 6G), suggest-
ing that dephosphorylation of activated Smad2/3 by phospha-
tases may be a prerequisite for RanBP3 binding and nuclear
export. Indeed, the nuclear Smad phosphatase PPM1A facili-
tates, while receptor activation decreases, the RanBP3-
Smad2/3 association (Figure 6A). As un- or dephosphorylated
Smad2 is most likely not in complex with Smad4, these findings
support the notion that RanBP3-mediated Smad2/3 nuclear
export is downstream of Smad dephosphorylation and/or the
disassociation of Smad2/3 from Smad4. Thus, either unphos-
phorylated or recently dephosphorylated Smad2/3 serve as car-
gos for RanBP3-mediated nuclear export.
The function of RanBP3 in regulating Smad nuclear export is
restricted to the TGF-b pathway. RanBP3 selectively inhibits
activin/TGF-b, but not BMP, transcriptional responses in
mammalian cells (Figure 1H) and Xenopus embryos (Figure 1I),
in agreement with the cargo selection of RanBP3 (Figures 5A,
5B, and 5G). This supports the notion that distinct mechanisms
underlying R-Smad nuclear export operate in TGF-b and BMP
pathways. It has been shown that both Smad1 and Smad4 utilize
CRM1 to associate with NES in these Smads for their nuclear
export (Xiao et al., 2001, 2003). This process is thus susceptible
to treatment with LMB, which impairs the function of CRM1. In
contrast, nuclear export of Smad2/3 is resistant to LMB (Inman
et al., 2002b; Nicolas et al., 2004; Schmierer and Hill, 2005). It
is reported that Exportin 4, which is LMB-insensitive, interacts
with Smad3 and promotes its nuclear export. It is of importance
to note that the Exportin-4-binding region locates in the MH2
domain and is well conserved among all R-Smads (Kurisaki
et al., 2006). It is thus possible that Exportin 4 may represent
a general exporter for all Smads. In contrast, our data presented
herein clearly suggest that RanBP3 selectively interacts with
Smad2/3, through a cooperative binding to both the MH1 and
MH2 domains, and specifically mediates the export of Smad2/
3 out of the nucleus.
The functional consequence of RanBP3-dependent nuclear
export of Smad2/3 is also assessed in our studies. The activity
of RanBP3 controls the nuclear Smad2/3 level, which correlates
well with the strength of the TGF-b signaling. Despite a few
studies on Smad nuclear export, the physiological conse-
quences of Smad nuclear export in TGF-b signaling have rarely
been examined. It is reasonable to speculate that TGF-b
signaling should be short-lived or impaired when Smad2/3354 Developmental Cell 16, 345–357, March 17, 2009 ª2009 Elsevieproteins are forced out of the nucleus. Indeed, overexpression
of RanBP3 dampens Smad2/3-mediated transcriptional res-
ponses both in mammalian cells and in Xenopus embryos
(Figures 1 and 2). Conversely, knockdown of RanBP3 expression
causes retention of Smad2/3 in the nucleus and enhances TGF-b
responses. A similar outcome can be achieved by disrupting the
endogenous RanBP3-Smad2/3 interaction (Figure 7). Consistent
with its inability to bind to Smad1 (and presumably Smad5 and
Smad8), RanBP3 has no effect on BMP-induced transcriptional
responses in mammalian cells and in Xenopus embryos (Figures
1D and 1I). This further supports the notion that distinct mecha-
nisms underlying R-Smad nuclear export operate in TGF-b and
BMP pathways.
The observation that inhibition of RanBP3 enhances TGF-b
signaling seems to contradict with a previous model, which
implies that continuous nucleocytoplasmic shuttling is required
for continuous TGF-b signaling (Schmierer and Hill, 2005). This
simplified model has not taken into account newly synthesized
Smads (which can transmit signals into the nucleus) and the
turnover of existing Smads. In the RanBP3 knockdown cells,
there is significant accumulation of dephosphorylated Smad2/3.
Could the dephosphorylated Smad2/3 in the nucleus be partially
active? Indeed, unphosphorylated Smad2 exhibits some tran-
scriptional activity on in vitro chromatin templates (Ross et al.,
2006). Alternatively, dephosphorylated Smad2/3 could be re-
phosphorylated by unknown kinase(s) in the nucleus; however,
this seems unlikely, based on our observation that knockdown of
RanBP3 did not dramatically increase the level of P-Smad2/3
in the nucleus (Figure 3D). Thus, the exact underlyingmechanism
of how accumulation of dephosphorylated Smad2/3 in the
nucleus ultimately leads to increased TGF-b signaling remains
to be further elucidated.
Our studies suggest that dephosphorylation of Smad2 and
Smad3 by PPM1A (and/or other Smad phosphatases) precedes
their nuclear export by RanBP3. However, a question arises
about how RanBP3 facilitates nuclear export of Smad2/3.
RanBP3 can partner with CRM1 in some cases, and it also binds
weakly to nuclear pore components in vitro (Englmeier et al.,
2001) as well as small GTPase Ran (Mueller et al., 1998; Englme-
ier et al., 2001). Since inhibition of CRM1 by LMB does not
promote nuclear accumulation of Smad2/3 (Xu et al., 2002; Kur-
isaki et al., 2006), the chance that CRM1 is involved in RanBP3-
mediated export of Smad2/3 is rather slim. RanBP3-R can
disrupt the RanBP3-Smad2/3 interaction, dominantly inhibit
Smad2 export, and enhance TGF-b transcriptional responses
(Figures 7C and 7D), suggesting that the N-terminal region of
RanBP3 is apparently needed for the export process. As the
N-terminal sequences contain FXFGmotifs that are homologous
to those in certain nucleoporins, we favor the idea that RanBP3
may act directly as a nuclear exporter for Smad2/3 (Figure 7E).
This notion is supported by recent discoveries that RanBP3
enhances nuclear export of b-catenin to terminate Wnt signaling
(Hendriksen et al., 2005) and is a negative regulator for STAT92E
nuclear accumulation in Drosophila (Baeg et al., 2005). The
similar dependence of Smad2/3 and b-catenin on RanBP3 for
nuclear export suggests that RanBP3may represent a new class
of nuclear exporter, which regulates the localization of key
signaling components to determine the duration and the strength
of signals in diverse signaling pathways.r Inc.
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Expression Plasmids and Antibodies
Details on plasmids and antibodies used/made in the study are provided in the
Supplemental Data.
Cell Lines and Transfection
Human HaCaT, HEK293T, and HepG2 cells were grown as described previ-
ously (Feng et al., 1998, 2000; Lin et al., 2006). HaCaT cells stably expressing
EGFP-Smad2 were kindly provided by Caroline Hill (Nicolas et al., 2004).
C2C12 cells were maintained as undifferentiated myoblasts in Dulbecco’s
modified Eagle’s medium with high glucose supplemented with 10% fetal
bovine serum. HaCaT cells were transfected with SuperFect (QIAGEN),
HEK293T cells and HepG2 cells with Lipofectin (Invitrogen), and C2C12 cells
with LipofectAmine (Invitrogen).
Transcription Reporter Assays
Reporter plasmids SBE-Luc, p21-Luc (a gift of Bert Vogelstein), p15-Luc (a gift
of Xiao-Fan Wang), and p800-Luc (a gift of David Luskutoff) were used to
measure TGF-b-induced transcription. Plasmid Id1-Luc (a gift of Peter ten
Dijke) was used to measure BMP-induced transcription. pSVbgal (Promega),
which expresses b-galactosidase under the control of the SV40 early
promoter, was cotransfected to allow normalization of transfection efficiency.
The total amount of transfected DNA was adjusted to the same amount by
addition of vector DNA when necessary. Reporter assays were carried out
as described (Feng et al., 2000). Briefly, 20 to 24 hr after transfection, cells
were treated with TGF-b1 (2 ng/ml) or BMP2 (50 ng/ml) for 24 hr. Cells were
then harvested for measurement of luciferase and b-galactosidase activities.
All assays were done in duplicate, and all values were normalized for transfec-
tion efficiency against b-galactosidase activities.
RNA Interference
The target sequences of shRNA-494 (nt 494–512 of coding region,
AGAGCCCCAGAAAAATGAG) and shRNA-676 (nt 676–694, CCGCAACGA
ACTATTTCCT) (targeting both human RanBP3a and RanBP3b) were previ-
ously described (Hendriksen et al., 2005). Annealed sense and antisense
DNA oligonucleotides were cloned into pSRG vector (Lin et al., 2006). Stable
HaCaT cell lines expressing shRNA-494/676 or pSRG vector were generated
and selected with 2 mg/ml of puromycin.
GST Fusion Protein, In Vitro Protein Binding, and Pull-Down Assays
Glutathione S-transferase fusion proteins were prepared using a commercial
kit (Amersham Pharmacia Biotech). In vitro translated (TNT kit, Promega)
35S-labeled protein was precleared with 5 mg of GST protein for 1 hr and
then incubated with 5 mg of various GST-fusion proteins for 2 hr in the binding
buffer (50 mM TrisdHCl [pH 7.5], 120 mM NaCl, 2 mM EDTA, 0.1% NP40).
35S-labeled proteins bound to GST-fusion proteins were retrieved on gluta-
thione-Sepharose beads, separated by SDS-PAGE, and visualized by autora-
diography. For comparing the binding of phosphorylated or unphosphorylated
Smad2 to RanBP3, 500 ng of recombinant Smad2MH2 or phosphorylated
Smad2MH2 (aa 241–467) (Lin et al., 2006) was incubated with GST-RanBP3.
RanBP3-bound Smad2MH2 was examined via western blot analysis.
Cell Fractionation and In Vitro Export Assay
HaCaT parental or its stable cells were treated with SB431542 at time periods
indicated in the text and harvested with fractionation buffer (10 mM HEPES
[pH 7.9], 1.5 mMMgCl2, 10 mM KCl, 0.5 mM DTT, 0.5% NP-40, and protease
inhibitors) for 20 min on ice and then fractionated by centrifugation. The frac-
tions were analyzed on SDS-PAGE and subsequent western blot analysis
(Figure 3D).
HaCaT cells stably expressing GFP-Smad2 cells were first treated with
TGF-b to induce nuclear accumulation of Smad2 (Figures 4A and 4B). Cells
were permeabilized with digitonin on ice for 5 min and then thoroughly washed
three times with a cold transport buffer (20 mM HEPES [pH 7.3], 110 mM
potassium acetate, 5 mM sodium acetate, 2 mM DTT, 1 mM GTP, 1.0 mM
EGTA, and proteinase inhibitor). Cells were incubated for 60 min at 30C in
the transport buffer with addition of ATP regeneration system (Sigma; 1 mM
ATP, 5 mM creatine phosphate, and 20 U/ml creatine phosphokinase) andDeveloRanBP3 or Ran. RanBP3 proteins were prepared from GST-RanBP3 by
removing GST with Precission (Amersham), and Ran proteins were enriched
by anti-Flag immunoprecipitation of cell lysates from HEK293T cells express-
ing Flag-Ran and eluted with Flag-peptide (Sigma). Cells were then rinsed
three times with the cold transport buffer. Excess buffer was removed, and
permeabilized cells were resolved in SDS loading buffer. The level of GFP-
Smad2 was then analyzed by western blot analysis.
Quantitative Smad2 Export Assay
A quantitative analysis of nuclear transport of Smad2 was previously
described (Xu et al., 2002; Lin et al., 2006), using MS2 coat protein-fused
Smad2 (gift of Joan Massague´) and pDM128/8xMS2 export reporter system
(gift of Bryan Cullen) (Cullen, 2004). Briefly, HEK293T cells were transfected
with plasmids for MS2-Smad2, CAT reporter pDM128/8xMS2, and b-galacto-
sidase plasmid (for normalization) and additional factors under examination.
Forty-five hours after transfection, cell lysates were analyzed for CAT activity
using an ELISA-based assay (Roche). Relative export activity was calculated
by normalizing the CAT activity with b-galactosidase activity in each sample.
DNA Pull-Down Assay
The DNA pull-down assay was essentially carried out as previously described
(Feng et al., 2000, 2002). Briefly, HaCaT parental or its stable cells were treated
with or without TGF-b for 2 hr and collected in lysis buffer (10 mM HEPES
[pH 7.5], 150 mM NaCl, 1 mM MgCl2, 0.5 mM EDTA, 0.5 mM DTT, and 0.1%
NP-40, 10% glycerol). The cell lysates were incubated with 30 pmol biotiny-
lated SBE oligonucleotides and 5 mg of poly(dI-dC) at 4C for 16 hr. DNA-
bound proteins were collected with streptavidin beads (Dynabeads M-280
Invitrogen) for 2 hr, washed extensively with the lysis buffer, and examined
by western blotting.
Immunoprecipitation and Western Blot Analysis
Endogenous or epitope-tagged proteins were immunoprecipitated from cell
lysates by the appropriate antibody affinity gel as indicated in the text and
figure legends. After extensive washes, immunoprecipitated proteins were
eluted in SDS sample loading buffer (Bio-Rad), separated by SDS-PAGE,
transferred to nitrocellulose (Pierce), and detected in western blots with appro-
priate primary antibodies coupled with horseradish peroxidase-conjugated
secondary antibody by chemiluminescence (Pierce).
Cell Proliferation Assays
Cells were grown in 96-well plates (3000 cells per well) in cell culture medium
supplemented with 0.02% fetal bovine serum (FBS) overnight before TGF-b
treatment. Cell proliferation was measured in duplicates for 3 days. Each
harvest was incubated with 20 ml of CellTiter 96 AQueous One Solution
Reagent (Promega) for 3 hr at 37C in the 5% CO2 incubator. The absorbance
at 490 nm was obtained using a VersaMax microplate reader (Molecular
Devices).
Xenopus Gene Expression Analysis
RNAs used for microinjection into Xenopus embryos were synthesized
with SP6 RNA polymerase using mMessage mMachine kit (Ambion). DNA
templates were AscI-linearized pCS105-RanBP3, pCS105-RanBP3-wv,
EcoRI-linearized pSP64T-activin, and AscI-linearized pCS105-BMP4. RNAs
were injected alone or in combination into the animal poles of two-cell stage
embryos. The doses of RNAs used were RanBP3 or RanBP3-wv (1 ng), activin
(1 pg), and BMP4 (20 pg). Ectodermal explants (animal caps) from injected
embryos were obtained at blastula stages (stage 9) and incubated to gastrula
stages (stage 11), at which time total RNA was extracted from these caps, and
the gene expression pattern was analyzed by reverse transcription (RT)-PCR.
The primers used in RT-PCR were as described (Chang et al., 1997).
Real-Time RT-PCR
Real-time RT-PCR (qRT-PCR) was carried out using Assay-on-Demand kits
(Applied Biosystem) and as previously described (Lin et al., 2006). Briefly, total
RNAswere prepared using TriZol reagent (Invitrogen) fromHaCaT cells. mRNA
levels of target genes p15, p21, and PAI-1 were normalized against 18S RNA.
Each target was measured in triplicate.pmental Cell 16, 345–357, March 17, 2009 ª2009 Elsevier Inc. 355
Developmental Cell
RanBP3 Terminates Smad2/3 SignalingBimolecular Fluorescence Complementation
To set up a bimolecular fluorescence complementation (BiFC) system (Hu
et al., 2002), we created two expression plasmids, pXF1YN and pXF1YC,
that contain aa 1–154 of enhanced YFP (designated YN) or 155–238 (desig-
nated YC), respectively. YN- or YC-tagged Smads or RanBP3b were con-
structed by inserting the corresponding coding sequences into EcoRI and
SalI sites of pXF1YN or pXF1YC. These expression plasmids were transfected
into HaCaT cells, and 48 hr after transfection, the fluorescence production was
detected with a Zeiss Axiovert 200M microscope.
Immunofluorescence
Cells grown on coverslips were fixed with 4% formaldehyde for 30 min at 4C,
followed by 0.5% Triton X-100 treatment for 30 min, and blocked with 5%milk
in PEM buffer (400 mM Potassium PIPES [pH 6.8], 0.8 mM EGTA, 5 mM
MgCl2). Cells were then probed with primary antibodies, followed by Alexa
Fluor 546 or Alexa Fluor 594 secondary antibody (Molecular Probes). Fluores-
cence images were acquired with a Zeiss Axiovert 200M microscope.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, Supple-
mental References, and four figures and can be found with this article
online at http://www.cell.com/developmental-cell/supplemental/S1534-5807
(09)00050-1/.
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